reference/9529050

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9529050

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Comparative Study\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	629
issn	0028-4793 1533-4406
issueIdentifier	7
pageRange	617-629
publicationName	The New England journal of medicine
startingPage	617
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_2f27b383cca2565ad499e55bb534e669 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_665d7d8b26be61d84f23b5abd7000da9
bibliographicCitation	DiNardo CD, Jonas BA, Pullarkat V, Thirman MJ, Garcia JS, Wei AH, Konopleva M, Döhner H, Letai A, Fenaux P, Koller E, Havelange V, Leber B, Esteve J, Wang J, Pejsa V, Hájek R, Porkka K, Illés Á, Lavie D, Lemoli RM, Yamamoto K, Yoon SS, Jang JH, Yeh SP, Turgut M, Hong WJ, Zhou Y, Potluri J, Pratz KW. Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia. N Engl J Med. 2020 Aug 13;383(7):617–29. doi: 10.1056/nejmoa2012971. PMID: 32786187.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_430091c08ead2b443c6ac7546e51a7f8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cd521332af4479678794151481e3cb1d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_34fbc359e3ff8d9c9619fdd23027026b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2542928ffd52f173d872d262019e5fa8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef30ec982f5947c47e46f6c68284d6cb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_98acad2d5a6dc3d0cff66c69186da01c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_10d2399f9971db434ab7ac46ba51ecc1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_79c38485732408a42a536bc8b1d1e754 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_58a3c23fd8c904e810340b85eb35dbae http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_96c00cbd00c517cb8c12e77ea10c989b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_01e79849b230499c5bcef41d86cb7484 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fa99feafa81773a3c107ea25d26b7226 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c96eee10f828b57fe806d666095a72e9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_37968375135296ff9b1243527bb4bc91 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8ecb455670ab4e97c48759cd26b2fc8e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7aff9659b50bebf48a6a1f2edd65b1be http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8c5ea96bf86f7ed567b9bad622872f97 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4c0818b14b41de435f28800bae67062c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3afa4f709a073293562ef2601c8e8acd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e8d63fc4f03dae41b26c485acb13a56 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_996b8c845e8f05f4d36b1cc267e1dbcf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_382ed1d953da87a5de19c042cc711bb2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d0fda6d0445ddc298832f819b552f85e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b401c328f599ec49b13045cec01419d5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ac5163c5e060d8eaf50af96a0571ecd3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_26949a5d936f8c483ab8eefa4a3871e4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eeedf35f1494577a66ae7c0156464e22 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d19b99cc082d7ce54010c64f62d4cb9c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a996002115b38fb3dc403c1ed59d3f36 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6ca06c004eea1c476b38ac1d7a3042f6
date	2020-08-13^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1056/nejmoa2012971 https://pubmed.ncbi.nlm.nih.gov/32786187
isPartOf	https://portal.issn.org/resource/ISSN/1533-4406 https://portal.issn.org/resource/ISSN/0028-4793 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5985
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
discusses	http://id.nlm.nih.gov/mesh/M0020790 http://id.nlm.nih.gov/mesh/M0028488 http://id.nlm.nih.gov/mesh/M0002060 http://id.nlm.nih.gov/mesh/M000614617
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D015470Q000188 http://id.nlm.nih.gov/mesh/D013449Q000008 http://id.nlm.nih.gov/mesh/D019086Q000008 http://id.nlm.nih.gov/mesh/D001374Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D013449Q000009 http://id.nlm.nih.gov/mesh/D007970Q000139 http://id.nlm.nih.gov/mesh/D013921Q000139 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D019086Q000009 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D011014Q000209 http://id.nlm.nih.gov/mesh/D057194 http://id.nlm.nih.gov/mesh/D001374Q000009 http://id.nlm.nih.gov/mesh/D012008 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D053208 http://id.nlm.nih.gov/mesh/D015470Q000401 http://id.nlm.nih.gov/mesh/D012074
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9408 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11445 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9444 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9731 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49846579

Showing number of triples: 1 to 87 of 87.